pmid,title,journal,year,drug,disease
40404934,"COVID-19 Alters Inflammatory, Mitochondrial, and Protein Clearance Pathway Genes: Potential Implications for New-onset Parkinsonism in Patients.",Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology,2025,Remdesivir,Parkinson's
37265903,Fulminant Clostridioides difficile Colitis With SARS-CoV-2 Infection.,Cureus,2023,Remdesivir,Parkinson's
36894709,Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection.,Nature genetics,2023,Remdesivir,Parkinson's
34075346,Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir.,ACS central science,2021,Remdesivir,Parkinson's
33495306,Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.,"Science (New York, N.Y.)",2021,Remdesivir,Parkinson's
33353566,Advantages of visualisations to evaluate and communicate adverse event information in randomised controlled trials.,Trials,2020,Remdesivir,Parkinson's
32881656,Targeting COVID-19 in Parkinson's Patients: Drugs Repurposed.,Current medicinal chemistry,2021,Remdesivir,Parkinson's
32707573,Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.,Nature,2020,Remdesivir,Parkinson's
